<DOC>
	<DOCNO>NCT02861118</DOCNO>
	<brief_summary>The purpose study evaluate impact co-morbidities profile treatment response inflammatory bowel disease ( IBD ) patient .</brief_summary>
	<brief_title>A Retrospective Observational Study Assess Impact Co-morbidities Treatment Response Inflammatory Bowel Disease</brief_title>
	<detailed_description>This retrospective , non-interventional , observational study include consecutive participant diagnose Ulcerative Colitis ( UC ) Crohn 's Disease ( CD ) start treatment biologics June 2011 June 2013 . This study look impact co-morbidities treatment response IBD patient . The study enroll approximately 400 patient : 200 UC patient 200 CD patient . This multicenter trial conduct Spain . Investigator collect retrospective data single visit participant start biologic treatment June 2011 June 2013 . Time since participant start biological treatment study visit lack treatment response treatment change constitute reference period study .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Adult participant ( age â‰¥18 ) . Were diagnosed UC CD accord `` World Gastroenterology Organization Practice Guidelines Diagnosis Management inflammatory bowel disease ( IBD ) 2010 '' . Who naive biologics start treatment biologics June 2011 June 2013 . Participants biological treatment prescribe accord clinical practice . Who give write informed consent . Were participate clinical trial study reference period . Participant , accord investigator 's criterion capable understand fill study questionnaire give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>